Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab

被引：3
|
作者：
Raquel, Calle-Calle [1 ]
Lucia, Triguero-Cueva [1 ]
Carmen, Valderrama-Martin [1 ]
Ana, Romero-Villarrubia [1 ]
Antonio, Tapia-Gomez [2 ]
Juan, Pasquau-Liano [2 ]
Carmen, Arnal-Garcia [1 ]
机构：
[1] Univ Hosp Granada, Dept Neurol Virgen Nieves, Granada, Spain
[2] Univ Hosp Granada, Unit Infect Dis Virgen Nieves, Granada, Spain
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 39卷
关键词：
Alemtuzumab; Multiple sclerosis; Toxoplasmosis;
D O I：
10.1016/j.msard.2019.101885
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Alemtuzumab induced anti-glomerular basement syndrome in a patient with relapsing-remitting multiple sclerosis
    Walendy, Victor
    Greinert, Daniel
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 346 - 347
  • [32] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence
    Bayas, Antonios
    Maeurer, Mathias
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 265 - 274
  • [33] Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
    Penkert, Horst
    Delbridge, Claire
    Wantia, Nina
    Wiestler, Benedikt
    Korn, Thomas
    JAMA NEUROLOGY, 2016, 73 (06) : 757 - 759
  • [34] Sporadic CJD in a patient with relapsing-remitting multiple sclerosis on an immunomodulatory treatment
    Gabelic, Tereza
    Habek, Mario
    Zerr, Inga
    Gawinecka, Joanna
    Pavlisa, Goran
    Brinar, Vesna V.
    ACTA NEUROLOGICA BELGICA, 2011, 111 (03) : 232 - 236
  • [35] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [36] Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report
    Mahmoudi, Farhad
    Emami, Sayed Ali
    Masaeli, Farid
    Rayatpisheh, Najmeh
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [37] Rehabilitation Challenges in a Patient with Relapsing-Remitting Multiple Sclerosis
    Aleksanyan, M.
    Choudhury, M.
    Oo, T. N.
    Shil, A. B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S272 - S272
  • [38] Alemtuzumab in The Treatment of Relapsing-Remitting Multiple Sclerosis (MS): Real World Experience from Singapore
    Quek, A. M. L.
    Lee, K. E.
    Soon, D.
    Ong, B. K. C.
    Tye, J. S. N.
    Tan, K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 463 - 464
  • [39] Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Wendy Gilmore
    Brett T. Lund
    Peili Li
    Alex M. Levy
    Eve E. Kelland
    Omid Akbari
    Susan Groshen
    Steven Yong Cen
    Daniel Pelletier
    Leslie P. Weiner
    Adil Javed
    Jeffrey E. Dunn
    Anthony L. Traboulsee
    Journal of Neuroinflammation, 17
  • [40] Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe
    Alcala, Carmen
    Gascon, F.
    Perez-Miralles, Francisco
    Dominguez, J. A.
    Gil-Perotin, S.
    Casanova, B.
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 726 - 734
12345